These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3597287)

  • 21. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children.
    Saresella M; Marventano I; Guerini FR; Mancuso R; Ceresa L; Zanzottera M; Rusconi B; Maggioni E; Tinelli C; Clerici M
    Biol Psychiatry; 2009 Nov; 66(10):978-84. PubMed ID: 19699471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.
    Maluish AE; Ortaldo JR; Conlon JC; Sherwin SA; Leavitt R; Strong DM; Weirnik P; Oldham RK; Herberman RB
    J Immunol; 1983 Jul; 131(1):503-7. PubMed ID: 6863923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive activity of peritoneal fluid in women with endometriosis.
    Oosterlynck DJ; Meuleman C; Waer M; Koninckx PR; Vandeputte M
    Obstet Gynecol; 1993 Aug; 82(2):206-12. PubMed ID: 8336865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effect of qi-training on natural killer cell subsets and cytotoxic activity.
    Lee M; Kang CW; Ryu H
    Int J Neurosci; 2005 Feb; 115(2):285-97. PubMed ID: 15764007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
    Auer IO; Ziemer E; Sommer H
    Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circulating serum interferon and its effect on human natural killer cell activity].
    Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580
    [No Abstract]   [Full Text] [Related]  

  • 27. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytotoxic activity of K-lymphocytes (killer cells) in Hodgkin's disease].
    Górska B; Konopka L; Seyfried H; Pawelski S
    Pol Tyg Lek; 1980 Aug; 35(33):1249-51. PubMed ID: 7433209
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies of the mechanism of disorders of the natural killer cell activity in patients with systemic scleroderma].
    Rudnicka L; Majewski S; Błaszczyk M; Skiendzielewska A; Makieła B
    Przegl Dermatol; 1990; 77(4):252-4. PubMed ID: 2267353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease.
    Tapazoglou E; Prasad AS; Hill G; Brewer GJ; Kaplan J
    J Lab Clin Med; 1985 Jan; 105(1):19-22. PubMed ID: 3968462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cellular immunologic studies in pediatric and juvenile thyroid cancer].
    Boros P; Csáky G; Balázs G; Szegedi G
    Zentralbl Chir; 1986; 111(19):1179-82. PubMed ID: 3492839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytotoxic activity of lymphocytes in children with infectious mononucleosis].
    Konopka L; Krotochwil-Skrzypkowa M; Rudnicka G; Najberg G; Pawelski S
    Acta Haematol Pol; 1984; 15(1-2):9-19. PubMed ID: 6516718
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
    Yamada S; Miyagawa Y; Komiyama A; Akabane T
    Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibody-dependent and natural cellular cytotoxicity in patients with dilated cardiomyopathy].
    Bakhov NI; Aleksandrova LZ; Osipov SG; Naumov VG; Rudnev VI
    Ter Arkh; 1986; 58(10):62-7. PubMed ID: 3798351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels].
    Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of natural killer cell activity].
    Abo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
    [No Abstract]   [Full Text] [Related]  

  • 37. Age-related development of human natural killer cell activity.
    Noble RL; Warren RP
    N Engl J Med; 1985 Sep; 313(10):641-2. PubMed ID: 4022054
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural killer cell activity in depressive illness: preliminary report.
    Kronfol Z; Nair M; Goodson J; Goel K; Haskett R; Schwartz S
    Biol Psychiatry; 1989 Nov; 26(7):753-6. PubMed ID: 2804197
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of folate receptor autoantibodies in infantile autism.
    Ramaekers VT; Quadros EV; Sequeira JM
    Mol Psychiatry; 2013 Mar; 18(3):270-1. PubMed ID: 22488256
    [No Abstract]   [Full Text] [Related]  

  • 40. Natural killer cell activity in schizophrenia and schizoaffective disorder: a pilot study.
    McDaniel JS; Jewart RD; Eccard MB; Pollard WE; Caudle J; Stipetic M; Risby ED; Lewine R; Risch SC
    Schizophr Res; 1992 Dec; 8(2):125-8. PubMed ID: 1457390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.